StonvexLoading…
StonvexStonvexStonvexCore line items from HAS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2022 2022-12-25 |
|---|---|---|---|---|
Revenue | $4.70B | $4.14B | $5.00B | $5.86B |
Operating Income | $11.10M | $690.00M | $-1.54B | $407.70M |
Net Income | $-322.40M | $385.60M | $-1.49B | $203.50M |
EPS (Diluted) | $-2.30 | $2.75 | $-10.73 | $1.46 |
Total Assets | $5.55B | $6.34B | $6.54B | $9.30B |
Total Liabilities | $4.99B | $5.16B | $5.45B | $6.43B |
Cash & Equivalents | $776.60M | $695.00M | $545.40M | $513.10M |
Free Cash Flow OCF − CapEx | $829.90M | $760.20M | $590.10M | $244.70M |
Shares Outstanding | 140.20M | 140.30M | 138.80M | 138.90M |